|
Video: What is a Stock Split?
|
|
Oxygen Biotherapeutics is engaged in developing biotechnology products with a focus on oxygen delivery to specific target tissues. Co. is developing Oxycyte®, a systemic perfluorocarbon product for use in situations of acute ischemia, which is in clinical trial for the treatment of traumatic brain injury. Co. is also developing its topical products: Dermacyte® line of topical cosmetic products for skin health and other cosmetic benefits; and Wundecyte™ gel developed under a contract agreement with a lab in Virginia that is designed to be used as a wound-healing gel. Co. also has under development Vitavent™, an oxygen exchange fluid for facilitating the treatment of lung conditions. According to our OXBT split history records, OXBT has had 2 splits. | |
|
OXBT (OXBT) has 2 splits in our OXBT split history database. The first split for OXBT took place on November 09, 2009. This was a 1 for 15 reverse split, meaning for each 15 shares of OXBT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split. OXBT's second split took place on May 13, 2013. This was a 1 for 20 reverse split, meaning for each 20 shares of OXBT owned pre-split, the shareholder now owned 1 share. For example, a 66.6666666666667 share position pre-split, became a 3.33333333333333 share position following the split.
When a company such as OXBT conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the OXBT split history from start to finish, an original position size of 1000 shares would have turned into 3.33333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into OXBT shares, starting with a $10,000 purchase of OXBT, presented on a split-history-adjusted basis factoring in the complete OXBT split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
09/18/2014 |
|
Start price/share: |
$5.27 |
|
End price/share: |
$4.04 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-23.34% |
|
Annualized Gain: |
-57.17% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$7,666.00 |
|
Years: |
0.41 |
|
|
|
Date |
Ratio |
11/09/2009 | 1 for 15 | 05/13/2013 | 1 for 20 |
|
|